CORGI ONTO 2X DAILY ETF(ONTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONTX CORGI ONTO 2X DAILY ETF

交易中 07-22 14:54:30 EDT

19.76

-0.58

-2.86%

最高19.98	最低19.58	成交量1,505
今开19.98	昨收20.34	日振幅1.99%
总市值118.56万	流通市值118.56万	总股本6.00万
成交额2.98万	换手率2.51%	流通股本6.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONTX","market":"US","secType":"STK","nameCN":"CORGI ONTO 2X DAILY ETF","latestPrice":19.76,"timestamp":1784745954003,"preClose":20.3422,"halted":0,"volume":1505,"delay":0,"changeRate":-0.028620306554846417,"floatShares":60000,"shares":60000,"eps":0,"marketStatus":"交易中","change":-0.5822,"latestTime":"07-22 14:54:30 EDT","open":19.98,"high":19.98,"low":19.575,"amount":29840.846525,"amplitude":0.019909,"askPrice":20.04,"askSize":400,"bidPrice":19.88,"bidSize":400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1784750400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1374724800000,"exchange":"CBOE","adjPreClose":20.3422,"nav":17.7,"aum":1062000,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":20.3422,"preClose":20.3422,"latestTime":"17:54 EDT","volume":35,"amount":705.55,"timestamp":1784670897372,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.319397,"impliedVol":1.6867,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ONTX","defaultTab":"news","newsList":[{"id":"2422811621","title":"Onconova Therapeutics, Inc.盘中异动 股价大涨5.15%报0.925美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422811621","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422811621?lang=zh_cn&edition=full","pubTime":"2024-03-27 03:52","pubTimestamp":1711482734,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日03时52分，Onconova Therapeutics, Inc.股票出现异动，股价急速拉升5.15%。Onconova Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Onconova Therapeutics, Inc.公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327035214861e14f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327035214861e14f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2421787862","title":"Onconova Therapeutics Inc    预计每股亏损 25 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2421787862","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421787862?lang=zh_cn&edition=full","pubTime":"2024-03-23 05:01","pubTimestamp":1711141300,"startTime":"0","endTime":"0","summary":"   * Onconova Therapeutics Inc    预计将在3月25日公布截至2023年12月31日的业绩报告时显示季度收入增长(，预计)。* 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于宾夕法尼亚州纽敦的公司的营收预计将从一年前的5.6万美元增长16.7%，达到6.533万美元。* LSEG 分析师对 Onconova Therapeutics Inc 的平均预期是每股亏损 25 美分。* 华尔街对 Onconova Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，高于其 0.84 美元的最新收盘价。3月22日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2420207008","title":"Onconova Therapeutics, Inc.盘中异动 临近收盘大幅下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420207008","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420207008?lang=zh_cn&edition=full","pubTime":"2024-03-20 04:01","pubTimestamp":1710878470,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日04时01分，Onconova Therapeutics, Inc.股票出现异动，股价大幅下跌5.17%。Onconova Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Onconova Therapeutics, Inc.公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032004011087e7a224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032004011087e7a224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2420082154","title":"Onconova Therapeutics, Inc.盘中异动 股价大涨5.60%报0.879美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420082154","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420082154?lang=zh_cn&edition=full","pubTime":"2024-03-18 22:25","pubTimestamp":1710771904,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日22时25分，Onconova Therapeutics, Inc.股票出现波动，股价急速拉升5.60%。Onconova Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Onconova Therapeutics, Inc.公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318222505861df207&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318222505861df207&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2419872641","title":"Onconova Therapeutics Inc    预计每股亏损 25 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2419872641","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419872641?lang=zh_cn&edition=full","pubTime":"2024-03-16 04:27","pubTimestamp":1710534463,"startTime":"0","endTime":"0","summary":"   * Onconova Therapeutics Inc    预计将在3月18日公布截至2023年12月31日的业绩报告时显示季度收入增长(，预计)。* 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于宾夕法尼亚州纽敦的公司的营收预计将从一年前的5.6万美元增长16.7%，达到6.533万美元。* LSEG 分析师对 Onconova Therapeutics Inc 的平均预期是每股亏损 25 美分。* 华尔街对 Onconova Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，高于其 0.90 美元的最新收盘价。3月15日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2419970480","title":"Onconova Therapeutics, Inc.盘中异动 股价大跌5.77%报0.851美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419970480","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419970480?lang=zh_cn&edition=full","pubTime":"2024-03-15 22:29","pubTimestamp":1710512952,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日22时29分，Onconova Therapeutics, Inc.股票出现异动，股价急速下跌5.77%。Onconova Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Onconova Therapeutics, Inc.公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152229127a4d16ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152229127a4d16ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2419931744","title":"Onconova Therapeutics, Inc.盘中异动 下午盘股价大跌6.46%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419931744","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419931744?lang=zh_cn&edition=full","pubTime":"2024-03-15 03:02","pubTimestamp":1710442963,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日03时02分，Onconova Therapeutics, Inc.股票出现异动，股价大幅跳水6.46%。截至发稿，该股报0.870美元/股，成交量6.1037万股，换手率0.29%，振幅8.60%。Onconova Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。Onconova Therapeutics, Inc.公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。其候选产品口服rigosertib目前正在剂量递增和扩展1期中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150302437a4cc17f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150302437a4cc17f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2419658601","title":"Onconova Therapeutics, Inc.盘中异动 股价大涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419658601","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419658601?lang=zh_cn&edition=full","pubTime":"2024-03-14 01:20","pubTimestamp":1710350415,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日01时20分，Onconova Therapeutics, Inc.股票出现异动，股价大幅拉升5.94%。Onconova Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Onconova Therapeutics, Inc.公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031401201587e78995&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031401201587e78995&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2417450065","title":"Onconova Therapeutics, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417450065","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417450065?lang=zh_cn&edition=full","pubTime":"2024-03-08 23:20","pubTimestamp":1709911229,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日23时20分，Onconova Therapeutics, Inc.股票出现波动，股价急速上涨5.45%。Onconova Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Onconova Therapeutics, Inc.公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。其候选产品口服rigosertib目前正在剂量递增和扩展1期中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082320297a4ae1b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082320297a4ae1b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2417642425","title":"Onconova Therapeutics, Inc.盘中异动 下午盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417642425","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417642425?lang=zh_cn&edition=full","pubTime":"2024-03-06 02:59","pubTimestamp":1709665186,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日02时59分，Onconova Therapeutics, Inc.股票出现异动，股价大幅下挫5.25%。Onconova Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。Onconova Therapeutics, Inc.公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。其候选产品口服rigosertib目前正在剂量递增和扩展1期中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306025947861db771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306025947861db771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2417127359","title":"Onconova Therapeutics, Inc.盘中异动 股价大涨5.43%报0.875美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417127359","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417127359?lang=zh_cn&edition=full","pubTime":"2024-03-05 01:34","pubTimestamp":1709573662,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日01时34分，Onconova Therapeutics, Inc.股票出现波动，股价快速上涨5.43%。截至发稿，该股报0.875美元/股，成交量12.68万股，换手率0.60%，振幅6.10%。Onconova Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Onconova Therapeutics, Inc.公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。其候选产品口服rigosertib目前正在剂量递增和扩展1期中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030501342287e75b8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030501342287e75b8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2416675125","title":"Onconova Therapeutics, Inc.盘中异动 下午盘股价大涨5.78%报0.835美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416675125","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416675125?lang=zh_cn&edition=full","pubTime":"2024-03-02 04:05","pubTimestamp":1709323551,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日04时05分，Onconova Therapeutics, Inc.股票出现波动，股价大幅上涨5.78%。截至发稿，该股报0.835美元/股，成交量9.0298万股，换手率0.43%，振幅3.17%。Onconova Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.47%。Onconova Therapeutics, Inc.公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。其候选产品口服rigosertib目前正在剂量递增和扩展1期中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030204055187e75526&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030204055187e75526&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2415370411","title":"Onconova Therapeutics Inc盘中异动 临近午盘股价大跌6.07%报0.790美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415370411","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2415370411?lang=zh_cn&edition=full","pubTime":"2024-02-29 00:59","pubTimestamp":1709139552,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日00时59分，Onconova Therapeutics Inc股票出现波动，股价快速下跌6.07%。Onconova Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc涨幅较大，Adial Pharmaceuticals Inc、Vivani Medical Inc、Revelation Biosciences Inc较为活跃，换手率分别为5253.90%、208.81%、85.49%，振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc，振幅分别为424.75%、219.84%、121.76%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402290059127a47ca42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402290059127a47ca42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2414801161","title":"Onconova Therapeutics Inc盘中异动 股价大涨5.36%报0.790美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414801161","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2414801161?lang=zh_cn&edition=full","pubTime":"2024-02-27 23:50","pubTimestamp":1709049035,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日23时50分，Onconova Therapeutics Inc股票出现异动，股价大幅上涨5.36%。截至发稿，该股报0.790美元/股，成交量4.6277万股，换手率0.22%，振幅4.69%。Onconova Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.26%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022723503679151d81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022723503679151d81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2412103260","title":"Onconova Therapeutics Inc盘中异动 股价大涨5.58%报0.707美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2412103260","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2412103260?lang=zh_cn&edition=full","pubTime":"2024-02-20 22:32","pubTimestamp":1708439523,"startTime":"0","endTime":"0","summary":"北京时间2024年02月20日22时32分，Onconova Therapeutics Inc股票出现波动，股价急速上涨5.58%。截至发稿，该股报0.707美元/股，成交量1.6609万股，换手率0.08%，振幅3.12%。Onconova Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.36%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022320387e71417&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022320387e71417&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2411536613","title":"Onconova Therapeutics Inc盘中异动 下午盘大幅下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411536613","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2411536613?lang=zh_cn&edition=full","pubTime":"2024-02-15 04:13","pubTimestamp":1707941616,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日04时13分，Onconova Therapeutics Inc股票出现异动，股价大幅下挫5.04%。Onconova Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.01%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402150413377a43af84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402150413377a43af84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2408880651","title":"Onconova Therapeutics Inc盘中异动 股价大涨7.20%报0.730美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408880651","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2408880651?lang=zh_cn&edition=full","pubTime":"2024-02-02 01:09","pubTimestamp":1706807387,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日01时09分，Onconova Therapeutics Inc股票出现异动，股价大幅上涨7.20%。截至发稿，该股报0.730美元/股，成交量1.6212万股，换手率0.08%，振幅2.70%。Onconova Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.65%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202010947861d0583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202010947861d0583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2406715344","title":"Onconova Therapeutics Inc盘中异动 股价大涨5.05%报0.707美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406715344","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2406715344?lang=zh_cn&edition=full","pubTime":"2024-01-27 01:14","pubTimestamp":1706289250,"startTime":"0","endTime":"0","summary":"北京时间2024年01月27日01时14分，Onconova Therapeutics Inc股票出现异动，股价急速上涨5.05%。截至发稿，该股报0.707美元/股，成交量4.2201万股，换手率0.20%，振幅5.77%。Onconova Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.29%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012701141187e69069&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012701141187e69069&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2406524375","title":"Onconova Therapeutics Inc盘中异动 早盘快速上涨5.21%报0.707美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406524375","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2406524375?lang=zh_cn&edition=full","pubTime":"2024-01-26 00:13","pubTimestamp":1706199203,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日00时13分，Onconova Therapeutics Inc股票出现波动，股价急速上涨5.21%。截至发稿，该股报0.707美元/股，成交量1.2983万股，换手率0.06%，振幅5.51%。Onconova Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.16%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。Onconova的新型专有多激酶抑制剂ON 123300目前正在中国进行剂量递增和扩展1期试验，并且IND已在美国备案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401260013247a3e6796&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401260013247a3e6796&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ONTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2400662392","title":"Onconova Therapeutics Inc盘中异动 早盘大幅上涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2400662392","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2400662392?lang=zh_cn&edition=full","pubTime":"2024-01-04 22:32","pubTimestamp":1704378764,"startTime":"0","endTime":"0","summary":"北京时间2024年01月04日22时32分，Onconova Therapeutics Inc股票出现波动，股价大幅上涨5.27%。Onconova Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Omega Therapeutics Inc、Avenue Therapeutics Inc、Kintara Therapeutics Inc涨幅较大，Kintara Therapeutics Inc、Avenue Therapeutics Inc、180 Life Sciences Corp较为活跃，换手率分别为809.97%、253.86%、191.40%，振幅较大的相关个股有Omega Therapeutics Inc、Avenue Therapeutics Inc、Onconova Therapeutics Inc，振幅分别为18.32%、13.38%、9.77%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家生物制药公司，致力于发现和开发治疗癌症的新产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240104223244861c8791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240104223244861c8791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onconova.com","stockEarnings":[{"period":"1week","weight":-0.1353},{"period":"1month","weight":-0.1934},{"period":"ytd","weight":-0.1934}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0021},{"period":"3month","weight":0.0521},{"period":"6month","weight":0.0861},{"period":"1year","weight":0.1901},{"period":"ytd","weight":0.0973}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Onconova Therapeutics, Inc.于1998年12月22日在特拉华注册成立，于1999年1月1日开始运营，是一个临床阶段的生物制药公司，致力于发现和开发新的小分子候选药物来治疗癌症。使用专有的化学平台，Onconova已经创建了一个针对特定细胞转变成肿瘤细胞的抗癌药物的广泛文库。 Rigosertib是公司最先进的候选产品，用于骨髓增生异常综合征，头部和颈部癌症的治疗，已经在临床研究中进行测试。到目前为止，其已经试验超过1,200例。产品形式包括静脉注射和口服。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.150141},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.033755},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.030072},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.081059},{"month":5,"riseRate":0.4,"avgChangeRate":-0.056797},{"month":6,"riseRate":0.8,"avgChangeRate":0.098892},{"month":7,"riseRate":0.2,"avgChangeRate":-0.016082},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.127847},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.118809},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.117793},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.065238},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.021172}],"exchange":"CBOE","name":"CORGI ONTO 2X DAILY ETF","nameEN":"CORGI ONTO 2X DAILY ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CORGI ONTO 2X DAILY ETF(ONTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CORGI ONTO 2X DAILY ETF(ONTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CORGI ONTO 2X DAILY ETF,ONTX,CORGI ONTO 2X DAILY ETF股票,CORGI ONTO 2X DAILY ETF股票老虎,CORGI ONTO 2X DAILY ETF股票老虎国际,CORGI ONTO 2X DAILY ETF行情,CORGI ONTO 2X DAILY ETF股票行情,CORGI ONTO 2X DAILY ETF股价,CORGI ONTO 2X DAILY ETF股市,CORGI ONTO 2X DAILY ETF股票价格,CORGI ONTO 2X DAILY ETF股票交易,CORGI ONTO 2X DAILY ETF股票购买,CORGI ONTO 2X DAILY ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CORGI ONTO 2X DAILY ETF(ONTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CORGI ONTO 2X DAILY ETF(ONTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}